Tsukamoto Taku 塚本拓

Researcher Number	50825049
Other IDs
Affiliation (Current)	2025: 京都府立医科大学, 医学(系)研究科(研究院), 助教
Affiliation (based on the past Project Information) *help	2019 – 2025: 京都府立医科大学, 医学(系)研究科(研究院), 助教
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related Except Principal Investigator Basic Section 54010:Hematology and medical oncology-related
Keywords	Principal Investigator B細胞受容体シグナル / マントル細胞リンパ腫 / 液-液相分離 / シグナロソーム / B細胞性リンパ腫 / BCRシグナル / galectin-3 / galectin-9 / Galectin-3 / 腫瘍微小環境 … More / 糖鎖修飾 / Galectin-9 / ナイーブB細胞 / Pulldown-seq / mir-17~92 cluster … More Except Principal Investigator 腫瘍・造血・身体環境の特性 / 機能連関 / 骨髄由来抑制系細胞 / 腫瘍免疫監視機構 / 血液腫瘍 / 創薬 / S6K / 分子標的治療 / MYC / 多発性骨髄腫 / 悪性リンパ腫 / AKT / PDPK1 / RSK2 Less

Characterization of tumor, hematopoietic cells, and body environment and their functional linkages to overcome anti-tumor immune destruction in hematologic tumors
- Principal Investigator
  
  黒田純也
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Kyoto Prefectural University of Medicine
Pathological roles of BCR signalosome in B cell lymphomaPrincipal Investigator
- Principal Investigator
  
  塚本拓
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Kyoto Prefectural University of Medicine
Generation of RSK2/AKT/S6K tripple inhibitor for mature lymphoid malignancies
- Principal Investigator
  
  黒田純也
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Kyoto Prefectural University of Medicine
Galectin-9 in mantle cell lymphomaPrincipal Investigator
- Principal Investigator
  
  Tsukamoto Taku
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Kyoto Prefectural University of Medicine
mir-17~92 cluster in mantle cell lymphomaPrincipal Investigator
- Principal Investigator
  
  Tsukamoto Taku
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Kyoto Prefectural University of Medicine

All 2023 2022 2021 2020

All Journal Article Presentation

[Journal Article] Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring system2023
- Author(s)
  Okamoto Haruya、Inoue Yu、Miyashita Akihiro、Kawaji-Kanayama Yuka、Chinen Shotaro、Fujino Takahiro、Tsukamoto Taku、Shimura Yuji、Mizutani Shinsuke、Kaneko Hiroto、Kuwahara-Ota Saeko、Fuchida Shin-ichi、Nishiyama Daichi、Hirakawa Koichi、Uchiyama Hitoji、Uoshima Nobuhiko、Kawata Eri、Kuroda Junya、KOTOSG investigators
- Journal Title
  
  International Journal of Hematology
  
  Volume: 118 Issue: 3 Pages: 323-332
- DOI
  10.1007/s12185-023-03627-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K15330, KAKENHI-PROJECT-21K16246
[Journal Article] Tumour‐derived exosomes promote the induction of monocytic myeloid‐derived suppressor cells from peripheral blood mononuclear cells by delivering <scp>miR</scp>‐106a‐5p and <scp>miR</scp>‐146a‐5p in multiple myeloma2023
- Author(s)
  Mizuhara Kentaro、Shimura Yuji、Tsukamoto Taku、Kanai Akinori、Kuwahara‐Ota Saeko、Yamaguchi Junko、Muramatsu Ayako、Okamoto Haruya、Taminishi‐Katsuragawa Yoko、Kawaji‐Kanayama Yuka、Isa Reiko、Mizutani Shinsuke、Inaba Toshiya、Kuroda Junya
- Journal Title
  
  British Journal of Haematology
  
  Volume: 203 Issue: 3 Pages: 426-438
- DOI
  10.1111/bjh.19049
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K15330, KAKENHI-PROJECT-22K08513, KAKENHI-PROJECT-21K16246
[Journal Article] Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B‐cell lymphomas2023
- Author(s)
  Katsuragawa‐Taminishi Yoko、Mizutani Shinsuke、Kawaji‐Kanayama Yuka、Onishi Akio、Okamoto Haruya、Isa Reiko、Mizuhara Kentaro、Muramatsu Ayako、Fujino Takahiro、Tsukamoto Taku、Shimura Yuji、Taniwaki Masafumi、Miyagawa‐Hayashino Aya、Konishi Eiichi、Kuroda Junya
- Journal Title
  
  Cancer Science
  
  Volume: 114 Issue: 12 Pages: 4691-4705
- DOI
  10.1111/cas.15995
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K15330, KAKENHI-PROJECT-22K08512, KAKENHI-PROJECT-21K16246
[Journal Article] Imaging flow cytometry-based multiplex FISH for three IGH translocations in multiple myeloma2023
- Author(s)
  Tsukamoto Taku、Kinoshita Masaki、Yamada Kazuhiro、Ito Hodaka、Yamaguchi Toshikazu、Chinen Yoshiaki、Mizutani Shinsuke、Fujino Takahiro、Kobayashi Tsutomu、Shimura Yuji、Inazawa Johji、Kuroda Junya
- Journal Title
  
  Journal of Human Genetics
  
  Volume: - Issue: 7 Pages: 507-514
- DOI
  10.1038/s10038-023-01136-2
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K16274, KAKENHI-PROJECT-23K15330, KAKENHI-PROJECT-21K16246
[Journal Article] miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signaling in mantle cell lymphoma2023
- Author(s)
  Kawaji‐Kanayama Yuka、Tsukamoto Taku、Nakano Masakazu、Tokuda Yuichi、Nagata Hiroaki、Mizuhara Kentaro、Katsuragawa‐Taminishi Yoko、Isa Reiko、Fujino Takahiro、Matsumura‐Kimoto Yayoi、Mizutani Shinsuke、Shimura Yuji、Taniwaki Masafumi、Tashiro Kei、Kuroda Junya
- Journal Title
  
  Cancer Science
  
  Volume: 115 Issue: 2 Pages: 452-464
- DOI
  10.1111/cas.16027
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K15330, KAKENHI-PROJECT-21K06840, KAKENHI-PROJECT-21K16246, KAKENHI-PROJECT-21H02687
[Journal Article] The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.2022
- Author(s)
  Isa R, Horinaka M, Tsukamoto T, Mizuhara K, Fujibayashi Y, Taminishi-Katsuragawa Y, Okamoto H, Yasuda S, Kawaji-Kanayama Y, Matsumura-Kimoto Y, Mizutani S, Shimura Y, Taniwaki M, Sakai T, Kuroda J.
- Journal Title
  
  Int J Mol Sci.
  
  Volume: 23 Issue: 6 Pages: 2919-2936
- DOI
  10.3390/ijms23062919
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08872, KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-19H03889, KAKENHI-PROJECT-21K16246, KAKENHI-PROJECT-21K16274
[Journal Article] Expression of activated B cell gene signature is predictive of the outcome of follicular lymphoma.2022
- Author(s)
  Tsukamoto T, Tokuda Y, Nakano M, Tashiro K, Kuroda J.
- Journal Title
  
  Blood Adv
  
  Volume: 6 Issue: 6 Pages: 1932-1936
- DOI
  10.1182/bloodadvances.2021005876
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08872, KAKENHI-PROJECT-21H02687, KAKENHI-PROJECT-20K07343, KAKENHI-PROJECT-21K06840, KAKENHI-PROJECT-21K16246
[Journal Article] Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma2022
- Author(s)
  Muramatsu A, Kobayashi T, Kawaji-Kanayama T, Uchiyama H, Sasaki N, Uoshima N, Nakao M, Takahashi R, Shimura K, Kaneko H, Kiyota M, Wada K, Chinen Y, Hirakawa K, Fuchida S, Shimazaki C, Mizutani S, Tsukamoto T, Shimura Y, Taniwaki M, Teramukai S, Kuroda J
- Journal Title
  
  Leukemia & Lymphoma
  
  Volume: 63 Issue: 7 Pages: 1678-1685
- DOI
  10.1080/10428194.2022.2038373
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K16246
[Journal Article] Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: <scp>CARTITUDE</scp> ‐1 (phase 2) Japanese cohort2022
- Author(s)
  Ri Masaki, Suzuki Kenshi, Ishida Tadao, Kuroda Junya, Tsukamoto Taku, Teshima Takanori, Goto Hideki, Jackson Carolyn C., Sun Huabin, Pacaud Lida, Fujikawa Ei, Yeh Tzu‐Min, Hatayama Tomoyoshi, Aida Kensuke, Sunagawa Yoshihiro, Iida Shinsuke
- Journal Title
  
  Cancer Science
  
  Volume: 113 Issue: 12 Pages: 4267-4276
- DOI
  10.1111/cas.15556
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K16246
[Journal Article] Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study2022
- Author(s)
  Mizuhara Kentaro, Kobayashi Tsutomu, Nakao Mitsushige, Takahashi Ryoichi, Kaneko Hiroto, Shimura Kazuho, Hirakawa Koichi, Uoshima Nobuhiko, Wada Katsuya, Kawata Eri, Isa Reiko, Fujino Takahiro, Tsukamoto Taku, Mizutani Shinsuke, Shimura Yuji, Yoneda Akiko, Watanabe Akihide, Sotozono Chie, Kuroda Junya
- Journal Title
  
  Cancer Medicine
  
  Volume: 12 Issue: 3 Pages: 3134-3144
- DOI
  10.1002/cam4.5237
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K16246, KAKENHI-PROJECT-21K16274
[Journal Article] Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma2021
- Author(s)
  Okamoto Haruya, Uoshima Nobuhiko, Muramatsu Ayako, Isa Reiko, Fujino Takahiro, Matsumura-Kimoto Yayoi, Tsukamoto Taku, Mizutani Shinsuke, Shimura Yuji, Kobayashi Tsutomu, Kawata Eri, Uchiyama Hitoji, Kuroda Junya, Kyoto Clinical Hematology Study Group Investigators
- Journal Title
  
  Diagnostics
  
  Volume: 11 Issue: 9 Pages: 1724-1724
- DOI
  10.3390/diagnostics11091724
- Data Source
  KAKENHI-PROJECT-21K16246
[Journal Article] Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder2021
- Author(s)
  Nagata Hiroaki, Kuriyama Kodai, Nishikawa Rina, Ohshiro Muneo, Yamamoto-Sugitani Mio, Fujimoto-Hirakawa Yoshiko, Matsumoto Yosuke, Iwai Toshiki, Tsukamoto Taku, Mizutani Shinsuke, Shimura Yuji, Kobayashi Tsutomu, Fukuda Wataru, Uchiyama Hitoji, Kuroda Junya
- Journal Title
  
  Annals of Hematology
  
  Volume: 100 Issue: 11 Pages: 2849-2850
- DOI
  10.1007/s00277-021-04645-2
- Data Source
  KAKENHI-PROJECT-21K16246
[Journal Article] EWSR1 overexpression is a pro-oncogenic event in multiple myeloma2021
- Author(s)
  Nishiyama D, Chinen Y, Isa R, Fujibayashi Y, Kuwahara-Ota S, Yamaguchi J, Takimoto-Shimomura T, Matsumura-Kimoto Y, Tsukamoto T, Shimura Y, Kobayashi T, Horiike S, Taniwaki M, Handa H, Kuroda J.
- Journal Title
  
  Int J Hematol
  
  Volume: 113 Issue: 3 Pages: 381-394
- DOI
  10.1007/s12185-020-03027-0
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08872, KAKENHI-PROJECT-19K17867
[Journal Article] Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma2020
- Author(s)
  Matsumura-Kimoto Y, Tsukamoto T, Shimura Y, Chinen Y, Tanba K, Kuwahara-Ota S, Fujibayashi Y, Nishiyama D, Isa R, Yamaguchi J, Kawaji-Kanayama Y, Kobayashi T, Horiike S, Taniwaki M, Kuroda J
- Journal Title
  
  Cancer Med
  
  Volume: 9 Issue: 14 Pages: 5185-5199
- DOI
  10.1002/cam4.3136
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08872, KAKENHI-PROJECT-19K17867
[Journal Article] BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach.2020
- Author(s)
  Tsukamoto T, Nakahata S, Sato R, Kanai A, Nakano M, Chinen Y, Maegawa-Matsui S, Matsumura-Kimoto Y, Takimoto-Shimomura T, Mizuno Y, Kuwahara-Ota S, Kawaji Y, Taniwaki M, Inaba T, Tashiro K, Morishita K, Kuroda J
- Journal Title
  
  Cancer Genomics Proteomics
  
  Volume: 17 Pages: 77-89
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K17867
[Journal Article] Aberrant BUB1 Overexpression Promotes Mitotic Segregation Errors and Chromosomal Instability in Multiple Myeloma2020
- Author(s)
  Fujibayashi Y, Isa R, Nishiyama D, Sakamoto-Inada N, Kawasumi N, Yamaguchi J, Kuwahara-Ota S, Matsumura-Kimoto Y, Tsukamoto T, Chinen Y, Shimura Y, Kobayashi T, Horiike S, Taniwaki M, Handa H, Kuroda J
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 8 Pages: 2206-2206
- DOI
  10.3390/cancers12082206
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08872, KAKENHI-PROJECT-18K08367, KAKENHI-PROJECT-19K17867
[Journal Article] Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities2020
- Author(s)
  Chinen Yoshiaki、Tsukamoto Taku、Maegawa-Matsui Saori、Matsumura-Kimoto Yayoi、Takimoto-Shimomura Tomoko、Tanba Kazuna、Mizuno Yoshimi、Fujibayashi Yuto、Kuwahara-Ota Saeko、Shimura Yuji、Kobayashi Tsutomu、Horiike Shigeo、Taniwaki Masafumi、Kuroda Junya
- Journal Title
  
  Experimental Hematology
  
  Volume: - Pages: 45-53.e1
- DOI
  10.1016/j.exphem.2020.02.004
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08872, KAKENHI-PROJECT-19K17867
[Journal Article] Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myeloma2020
- Author(s)
  Kuwahara-Ota S, Shimura Y, Steinebach C, Isa R, Yamaguchi J, Nishiyama D, Fujibayashi Y, Takimoto-Shimomura T, Mizuno Y, Matsumura-Kimoto Y, Tsukamoto T, Chinen Y, Kobayashi T, Horiike S, Taniwaki M, Gutschow M, Kuroda J
- Journal Title
  
  Br J Haematol
  
  Volume: 191 Issue: 5 Pages: 784-795
- DOI
  10.1111/bjh.16881
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08872, KAKENHI-PROJECT-18K16125, KAKENHI-PROJECT-19K17867
[Presentation] The anti-myeloma efficacy of TAS0612, a triple inhibitor for RSK, AKT, and S6K.2023
- Author(s)
  Okamoto H，Isa R，Muramatsu A，Mizuhara K，Taminishi Y，Kanayama Y，Tsukamoto T，Shimura Y，Mizutani S，Kuroda J.
- Organizer
  第85回日本血液学会学術総会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08512
[Presentation] The Activation Status of RSK2, but Not PDPK1 and AKT, Associates with the Prognosis of Diffuse Large B Cell Lymphoma.2023
- Author(s)
  4.Onishi A, Miyagawa-Hayashino A, Mizuhara K, Muramatsu A, Okamoto H, Kawaji-Kanayama Y, Katsuragawa-Taminishi Y, Fujino T, Tsukamoto T, Mizutani S, Shimura Y, Konishi E, Kuroda J.
- Organizer
  he American Society of Hematology 65th Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08512
[Presentation] RSK/AKT/S6Kトリプル阻害剤TAS0612の抗骨髄腫効果 The anti-myeloma efficacy of TAS0612, a triple inhibitor for RSK, AKT, and S6K.2023
- Author(s)
  2.岡本明也、伊佐怜子、村松彩子、水原健太郎、民西（桂川）葉子、金山（川路）悠加、藤野貴大、塚本拓、水谷信介、志村勇司、黒田純也.
- Organizer
  第48回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-22K08512
[Presentation] RSK/AKT/S6Kトリプル阻害剤 TAS0612の抗骨髄腫効果2023
- Author(s)
  岡本明也、伊佐怜子、村松彩子、水原健太郎、民西(桂川)葉子、金山（川路）悠加、塚本　拓、志村勇司、水谷信介、黒田純也
- Organizer
  第48回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-22K08512
[Presentation] TAS0612, a Triple Inhibitor for RSK, AKT, and S6K, Is a Promising Anti-Myeloma Agent Regardless of Types of Cytogenetic/Genetic Abnormality2023
- Author(s)
  3.Okamoto H, Mizutani S, Tsukamoto T, Katsuragawa-Taminishi Y, Isa R, Mizuhara K, Muramatsu A, Kawaji-Kanayama Y, Fujino T, Shimura Y, Kuroda J.
- Organizer
  The American Society of Hematology 65th Annual Meeting and Exposition
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08512
[Presentation] Prognostic impact of RSK2 activation status in diffuse large B cell lymphoma.2023
- Author(s)
  Onishi A，Miyagawa A，Mizuhara K，Muramatsu A，Okamoto H，Kawaji Y，Taminishi Y，Fujino T，Tsukamoto T，Mizutani S，Shimura Y，Konishi E，Kuroda J.
- Organizer
  第85回日本血液学会学術総会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08512

1. 黒田純也 (70433258)

# of Collaborated Projects: 2 results

# of Collaborated Products: 13 results
2. 水谷信介 (40883088)

# of Collaborated Projects: 1 results

# of Collaborated Products: 11 results
3. 志村勇司 (00714685)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Tsukamoto Taku 塚本 拓

Research Projects

Research Products

Co-Researchers

Characterization of tumor, hematopoietic cells, and body environment and their functional linkages to overcome anti-tumor immune destruction in hematologic tumors

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Pathological roles of BCR signalosome in B cell lymphomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Generation of RSK2/AKT/S6K tripple inhibitor for mature lymphoid malignancies

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Galectin-9 in mantle cell lymphomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

mir-17~92 cluster in mantle cell lymphomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring system2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Tumour‐derived exosomes promote the induction of monocytic myeloid‐derived suppressor cells from peripheral blood mononuclear cells by delivering <scp>miR</scp>‐106a‐5p and <scp>miR</scp>‐146a‐5p in multiple myeloma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B‐cell lymphomas2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Imaging flow cytometry-based multiplex FISH for three IGH translocations in multiple myeloma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signaling in mantle cell lymphoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Expression of activated B cell gene signature is predictive of the outcome of follicular lymphoma.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: <scp>CARTITUDE</scp> ‐1 (phase 2) Japanese cohort2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study2022

Tsukamoto Taku 塚本拓